{
    "id": "31e5cd99-015b-86fa-e063-6394a90ad41b",
    "code": {
        "code": "34391-3",
        "codeSystem": "2.16.840.1.113883.6.1",
        "displayName": "HUMAN PRESCRIPTION DRUG LABEL"
    },
    "name": "Sodium Fluoride F 18",
    "organization": "SOFIE Co.",
    "effectiveTime": "20250403",
    "ingredients": [
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "SODIUM FLUORIDE F-18",
            "code": "9L75099X6R"
        }
    ],
    "indications": "1 usage sodium fluoride f 18 injection, usp indicated diagnostic positron emission tomography ( pet ) imaging bone define areas altered osteogenic activity. sodium fluoride f 18 injection, usp radioactive diagnostic agent positron emission tomography ( pet ) indicated imaging bone define areas altered osteogenic activity ( 1 ) .",
    "contraindications": "4 none. none ( 4 ) .",
    "warningsAndPrecautions": "5 allergic reactions: injectable product, allergic anaphylaxis may occur. emergency resuscitation equipment personnel immediately available. ( 5.1 ) . cancer risk: sodium fluoride f 18 injection may increase risk cancer. smallest dose necessary imaging ensure safe handling protect patient health care worker ( 5.2 ) . ( 5 ) . 5.1 allergic injectable product, allergic anaphylaxis may occur. emergency resuscitation equipment personnel immediately available. 5.2 radiation risks sodium fluoride f 18 injection may increase risk cancer. carcinogenic mutagenic sodium fluoride f18 injection performed. smallest dose necessary imaging ensure safe handling protect patient health care worker [ ] . ( 2.1 )",
    "adverseReactions": "6 reported sodium fluoride f 18 injection based review published literature, publicly available reference sources, reaction reporting systems. however, completeness sources known. reported sodium fluoride f 18 injection based review published literature, publicly available reference sources, reaction reporting systems ( 6 ) . report suspected reactions, contact sofie co. 1-800-207-1865 fda 1-800-fda-1088 www.fda.gov/medwatch.",
    "indications_original": "1 INDICATIONS AND USAGE Sodium Fluoride F 18 Injection, USP is indicated for diagnostic positron emission tomography (PET) imaging of bone to define areas of altered osteogenic activity. Sodium Fluoride F 18 Injection, USP is a radioactive diagnostic agent for positron emission tomography (PET) indicated for imaging of bone to define areas of altered osteogenic activity (1) .",
    "contraindications_original": "4 CONTRAINDICATIONS None. None (4).",
    "warningsAndPrecautions_original": "5 WARNINGS AND PRECAUTIONS Allergic Reactions: As with any injectable drug product, allergic reactions and anaphylaxis may occur. Emergency resuscitation equipment and personnel should be immediately available. (5.1) . Cancer Risk: Sodium Fluoride F 18 Injection may increase the risk of cancer. Use the smallest dose necessary for imaging and ensure safe handling to protect the patient and health care worker (5.2) . (5) . 5.1 Allergic Reactions As with any injectable drug product, allergic reactions and anaphylaxis may occur. Emergency resuscitation equipment and personnel should be immediately available. 5.2 Radiation Risks Sodium Fluoride F 18 Injection may increase the risk of cancer. Carcinogenic and mutagenic studies with Sodium Fluoride F18 injection have not been performed. Use the smallest dose necessary for imaging and ensure safe handling to protect the patient and health care worker [ see Dosage and Administration ]. (2.1)",
    "adverseReactions_original": "6 ADVERSE REACTIONS No adverse reactions have been reported for Sodium Fluoride F 18 Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting systems. However, the completeness of these sources is not known. No adverse reactions have been reported for Sodium Fluoride F 18 Injection based on a review of the published literature, publicly available reference sources, and adverse drug reaction reporting systems (6) . To report SUSPECTED ADVERSE REACTIONS, contact SOFIE Co. at 1-800-207-1865 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch."
}